Kaspi.kz Statement on Misleading short-seller research
ALMATY, Kazakhstan, Sept. 19, 2024 (GLOBE NEWSWIRE) — The company is issuing the following statement following the research report published […]
ALMATY, Kazakhstan, Sept. 19, 2024 (GLOBE NEWSWIRE) — The company is issuing the following statement following the research report published […]
TORONTO, Ontario, Sept. 19, 2024 (GLOBE NEWSWIRE) — Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) is pleased to announce […]
GREENWICH, Conn., Sept. 19, 2024 (GLOBE NEWSWIRE) — Associated Capital Group, Inc. (“AC” or the “Company”) (NYSE:AC), today announced that […]
VANCOUVER, British Columbia, Sept. 19, 2024 (GLOBE NEWSWIRE) — CMC Metals Ltd. (TSX-V: CMB) (Frankfurt:ZM5P) (“CMC” or the “Company”) is […]
MONTRÉAL, 19 sept. 2024 (GLOBE NEWSWIRE) — Ressources Cerro de Pasco Inc. (CSE: CDPR) (Frankfurt: N8HP) (« CDPR » ou […]
MONTREAL, Sept. 19, 2024 (GLOBE NEWSWIRE) — Cerro de Pasco Resources Inc. (CSE: CDPR) (Frankfurt: N8HP) (“CDPR,” or the “Corporation”) […]
Nashville, TN, Sept. 19, 2024 (GLOBE NEWSWIRE) — IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC Holdings” or the “Company”), a leader […]
Bright Minds Biosciences announced the initiation of Phase 2 clinical trial of BMB-101 in a group of drug-resistant epilepsies and […]
HOUSTON, Sept. 19, 2024 (GLOBE NEWSWIRE) — FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued […]
Dr. Comenzo was the senior author of the landmark Andromeda trial results published in the New England Journal of Medicine […]